Northwest Investment Counselors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Northwest Investment Counselors's BIIB Position: Q1 2022 in Review
Northwest Investment Counselors sold out of Biogen (BIIB) in Q1 2022, closing a stake of 11 shares — an estimated $3K sold.
Northwest Investment Counselors first reported a position in BIIB in Q2 2017 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.
- Northwest Investment Counselors reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
- Northwest Investment Counselors sold 11 Biogen shares in Q1 2022, an estimated $3K.
- Northwest Investment Counselors first reported a position in Biogen in Q2 2017 and held it in 6 quarters.
- Northwest Investment Counselors's Biogen position peaked at $3K in Q4 2021.
- 953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.
Based on Northwest Investment Counselors's 13F filing for Q1 2022, filed 18 Apr 2022.